In 2017, the federal government introduced new regulations for the drug review board.
drug approval process
New drugs are approved later in Canada than in the United States and European Union.
Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.
Accepting FDA approvals could lead to earlier marketing availability in Canada.
Innovative new medicines can have a profound impact on the health and wellbeing of those stricken with illness. Unfortunately, Canadians are often denied these benefits for months, if not years, while they wait for their government to approve drugs already deemed safe and effective by regulators in the European Union and United States. Smarter regulation could save resources, reduce patient suffering, and improve the lives of Canadians.
New medicines are a central component of modern medical care, treating illness effectively, providing more comfortable treatment regimes, extending life and reducing disability, and sometimes offering new treatment options where none previously existed. However, these benefits come with the potential for harm, which is why governments around the world regulate access to new medicines.